M&A Deal Summary |
|
|---|---|
| Date | 2011-04-19 |
| Target | NovaMed Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | SciClone Pharmaceuticals |
| Sellers(s) | Eight Roads |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1989 |
| Sector | Life Science |
| Employees | 570 |
| Revenue | 160M USD (2016) |
SciClone Pharmaceuticals is a specialty pharmaceutical company with a substantial commercial business in China and a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. SciClone's proprietary lead product, ZADAXIN (thymalfasin), is approved in over 30 countries and may be used for the treatment of hepatitis B (HBV), hepatitis C (HCV), and certain cancers, and as an immune system enhancer, according to the local regulatory approvals. SciClone Pharmaceuticals was founded in 1989 and is based in Shanghai, China.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: China M&A | 1 of 1 |
| Year: 2011 M&A | 1 of 1 |
| Category | Private Equity Firm |
|---|---|
| Founded | 1969 |
| PE ASSETS | 11.0B USD |
| Size | Mega |
| Type | Sector Focused |
Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 124 |
| Sector: Life Science M&A | 4 of 51 |
| Type: Add-on Acquisition M&A Deals | 2 of 59 |
| Country: China M&A | 4 of 19 |
| Year: 2011 M&A | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-03-31 |
Acacia Pharma
Cambridge, United Kingdom Acacia Pharma is a pharmaceutical company specializing in the development of drugs for cancer supportive care. The growth in the cancer supportive care market has been driven by the increasing incidence of cancer, the expansion of effective cancer therapies and the desire to improve both the effectiveness of treatment and the quality of life of cancer patients. Acacia Pharma was founded in 2007 and is based in Cambridge, United Kingdom. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-06-23 |
Classteacher Learning Systems
Gurugram, India Classteacher Learning Systems is a pioneer in educational content in the country with over 85,000 classroom teaching modules, providing consulting and innovative technology solutions in the area of school education. Classteacher Learning Systems was founded in 1999 and is based in Gurugram, Haryana. |
Buy | - |
